To our knowledge this is the first study which linked post-surgical alterations in postprandial PYY and GLP1 hormones to achieved weight loss as well as to improved insulin resistance beyond first 12 months after weight loss interventions. The gene discussed is GCG; the disease is Insulin resistance.